Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J DeAngelo

Showing results (1-10 of 320) with videos related to

Pageof 32
Sort By:
Hematology. American Society of Hematology. Education Program|November 24, 2005
The treatment of adolescents and young adults with acute lymphoblastic leukemiaDaniel J DeAngelo
Clinical Advances in Hematology & Oncology : H&O|October 17, 2014
Switching drugs midstream for patients with chronic myeloid leukemiaDaniel J DeAngelo
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
ReviewDaniel J DeAngelo
Hematology/Oncology Clinics of North America|October 15, 2009
Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphomaDaniel J DeAngelo
Hematology. American Society of Hematology. Education Program|December 6, 2015
The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemiaDaniel J DeAngelo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Tailored Approaches to Induction Therapy for Acute Promyelocytic LeukemiaDaniel J DeAngelo
Hematology/Oncology Clinics of North America|November 8, 2011
Chronic myelogenous leukemia. PrefaceDaniel J DeAngelo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?Daniel J DeAngelo, Jerome Ritz
Expert Review of Hematology|October 27, 2017
Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemiaMarlise R Luskin, Daniel J DeAngelo
Journal of Geriatric Oncology|February 22, 2018
How to treat chronic myeloid leukemia (CML) in older adultsMarlise R Luskin, Daniel J DeAngelo
Pageof 32

Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
Hematology. American Society of Hematology. Education Program|November 24, 2005
The treatment of adolescents and young adults with acute lymphoblastic leukemiaDaniel J DeAngelo
Clinical Advances in Hematology & Oncology : H&O|October 17, 2014
Switching drugs midstream for patients with chronic myeloid leukemiaDaniel J DeAngelo
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
ReviewDaniel J DeAngelo
Hematology/Oncology Clinics of North America|October 15, 2009
Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphomaDaniel J DeAngelo
Hematology. American Society of Hematology. Education Program|December 6, 2015
The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemiaDaniel J DeAngelo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Tailored Approaches to Induction Therapy for Acute Promyelocytic LeukemiaDaniel J DeAngelo
Hematology/Oncology Clinics of North America|November 8, 2011
Chronic myelogenous leukemia. PrefaceDaniel J DeAngelo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?Daniel J DeAngelo, Jerome Ritz
Expert Review of Hematology|October 27, 2017
Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemiaMarlise R Luskin, Daniel J DeAngelo
Journal of Geriatric Oncology|February 22, 2018
How to treat chronic myeloid leukemia (CML) in older adultsMarlise R Luskin, Daniel J DeAngelo
Pageof 32